IUBio Biosequences .. Software .. Molbio soft .. Network News .. FTP

[Virology] Wanted: Scientist - Viral Genotyping, Cambridge MA

Rynak, John via virology%40net.bio.net (by Rynak.John from idenix.com)
Wed May 23 07:41:13 EST 2007

Scientist  - Viral Genotyping



Ability to interface with internal clinical operations or external
clinical vendors in regards the development of patient data list-sets,
and format clinical data .


Scanning and interpreting the recent literature to identify variation in
viral genes and signaling pathways that may be involved in viral
resistance and disease progression.


Review and analyze various genotyping data, and generation of complex
reports which will be utilized  in agency  required reports,
specifically in regards to resistance profiling.


Perform significance of Amino Acid Analysis and co-ordination of assays
over several programs (HCV, HBV, HIV) through various stages of clinical
development (Phase I-III).


Develop and maintain genotype data tracking system.


Review and audit all external genotyping data and reports to insure data





Phd in Genetics, Molecular Genetics, Virology, , Molecular Biology, or
Immunology, with an additional hands on experiencein Bioinformatics or


Previous SAS, ABI Sequencer software and advanced excel experience


Experience in the viral immergence of resistance,  viral genotyping or
viral genetics research.


Idenix offers an excellent benefits package including competitive
salary, equity compensation, major medical insurance, dental insurance,
401(k) plan participation, and group life and disability insurance.


To be considered for this position, please send your resume by email to
hr from idenix.com, or by mail to:

Human Resources
Idenix Pharmaceuticals
60 Hampshire Street
Cambridge, MA  02139 

www.idenix.com <http://www.idenix.com/> 


Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in
the discovery, development and commercialization of new treatments for
infectious diseases. Idenix has a broad pipeline of candidates which are
currently in or soon to be entering clinical trials for the treatment of
Hepatitis B, Hepatitis C and HIV. Idenix's lead compound telbivudine for
the treatment of Hepatitis B virus (HBV) is currently under review by
the FDA for marketing approval.



This email has been scanned by the MessageLabs Email Security System 
to prevent the transmission of viruses, spam and other unwanted content.

More information about the Virology mailing list

Send comments to us at biosci-help [At] net.bio.net